专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2020028152A1 RANSOMWARE INFECTION DETECTION IN FILESYSTEMS 审中-公开
公开(公告)号：WO2020028152A1
公开(公告)日：2020-02-06
申请号：PCT/US2019/043563
申请日：2019-07-26
申请人： CHEN, Oscar , WU, Di , REISNER, Benjamin , NOE, Matthew Edward
发明人： CHEN, Oscar , WU, Di , REISNER, Benjamin , NOE, Matthew Edward
IPC分类号： G06F21/56 , G06F21/53
摘要： Described herein is a system that detects ransomware infection in filesystems. The system detects ransomware infection by using backup data of machines. The system detects ransomware infection in two stages, ln the first stage, the system analyzes a filesystem's behavior. The filesystem's behavior can be obtained by loading the backup data and crawling the filesystem to create a filesystem metadata including information about file operations during a time interval. The filesystem determines a pattern of the file operations and compares the pattern to a normal patter to analyze the filesystem's behavior. If the filesystem's behavior is abnormal, the system proceeds to the second stage to analyze the content of the files to look for signs of encryption in the filesystem. The system combines the analysis of both stages to determine whether the filesystem is infected by ransomware.

2. 发明申请

WO2015047186A1 METHODS TO PROFILE MOLECULAR COMPLEXES BY USING PROXIMITY BAR-CODING 审中-公开
标题翻译：通过使用临时条形码来分析分子复合物的方法
公开(公告)号：WO2015047186A1
公开(公告)日：2015-04-02
申请号：PCT/SE2014/051133
申请日：2014-09-30
申请人： WU, Di
发明人： WU, Di
IPC分类号： C12Q1/68 , G01N33/53
CPC分类号： C12Q1/6806 , C12Q1/6827 , C12Q1/6874 , C12Q2525/161 , C12Q2565/501
摘要： The present invention relates to a method for studying constituents of individual molecular complexes by labelling the molecules belonging to the same complex with at least one set of molecular constructs, wherein each member of the set comprises a Unique Identifying Sequence (UIS), which is a nucleic acid sequence unique for each member of the set, and at least one Common Tag Sequence (CTS), which is a nucleic acid sequence common to all members of the set, by: -attaching the molecular construct to the complex by ligating or hybridizing the molecular construct to a nucleic acid molecule of the complex, or ligating or hybridizing the tag to a nucleic acid linked to an affinity binder that binds specifically to a constituent of the complex, -labelling the molecules belonging to the same complex by using the molecular construct tags as primers or templates in a nucleic acid polymerisation reaction, and -analysing the composition of the molecular complex by analysing the combinations of UISs and CTSs.
摘要翻译：本发明涉及通过用至少一组分子构建体标记属于同一复合物的分子来研究各个分子复合物的成分的方法，其中该组的每个成员包括唯一识别序列（UIS），其是所述组的每个成员唯一的核酸序列和至少一个通用标签序列（CTS），其是该组所有成员共有的核酸序列，通过：通过连接或杂交将分子构建体连接到复合物将该分子构建体与该复合体的核酸分子结合或连接或杂交该标记与与特异性结合该复合物成分的亲和性粘合剂连接的核酸， - 通过使用分子在核酸聚合反应中构建标签作为引物或模板，并通过分析U的组合来分析分子复合物的组成 ISs和CTSs。

3. 发明申请

WO2013162732A1 COMPOSITION AND METHOD FOR UPCONVERSION OF LIGHT AND DEVICES INCORPORATING SAME 审中-公开
标题翻译：用于与其并入的光和装置的上升的组合物和方法
公开(公告)号：WO2013162732A1
公开(公告)日：2013-10-31
申请号：PCT/US2013/030519
申请日：2013-03-12
申请人： THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY , DIONNE, Jennifer, Anne , SALLEO, Alberto , WU, Di, Meng
发明人： DIONNE, Jennifer, Anne , SALLEO, Alberto , WU, Di, Meng
IPC分类号： H01L31/055 , H01L31/0224
CPC分类号： H01L31/022425 , H01L31/022466 , H01L31/055 , Y02E10/52
摘要： An up-converting electrode and a solar cell that combines the up-converting electrode are disclosed. The up-converting electrode comprises a material that up-converts light from longer wavelengths to shorter wavelengths and an electrically conductive material. The electrically conductive material increases the efficiency of the up-converting material such that more light is up-converted. The up-converting electrode can also serve as an electrical contact for the solar cell.
摘要翻译：公开了一种组合上变换电极的上转换电极和太阳能电池。上变换电极包括将来自较长波长的光上变换成较短波长的材料和导电材料。导电材料增加了上转换材料的效率，使得更多的光被上变换。上变换电极还可以用作太阳能电池的电接触。

4. 发明申请

WO2011127857A3 PROCESSING METHOD, USER FACING PROVIDER EDGE (UPE) AND NETWORK FACING PROVIDER EDGE (NPE) FOR MULTICAST DATA STREAM 审中-公开
标题翻译：处理方法，用户提供者边缘（UPE）和网络提供商边缘（NPE）用于多媒体数据流
公开(公告)号：WO2011127857A3
公开(公告)日：2012-04-26
申请号：PCT/CN2011074195
申请日：2011-05-17
申请人： HUAWEI TECH CO LTD , WU DI , LING YI
发明人： WU DI , LING YI
IPC分类号： H04L12/56
CPC分类号： H04L12/185
摘要： Disclosed are a processing method, a User Facing Provider Edge (UPE) and a Network Facing Provider Edge (NPE) for multicast data stream, and the method includes: receiving a query message based on a group management protocol sent from the NPE, wherein the query message contains channel information (101); establishing channel list items corresponding to the channel information (102); receiving a report message which is based on the group management protocol, used to join into a multicast group and sent from a Custom Edge (CE), wherein the report message contains the channel information (103); associating the channel list items with the CE and forming multicast forwarding list items (104); according to the multicast forwarding list items, sending the multicast data stream received from the NPE to the CE (105). The present invention can save the time for the UPE to establish the channel list items, thus shorten the time delay for the CE to obtain the multicast data stream.
摘要翻译：公开了用于组播数据流的处理方法，用户面向提供者边缘（UPE）和网络面向提供者边缘（NPE），并且所述方法包括：基于从所述NPE发送的组管理协议接收查询消息，其中，查询消息包含频道信息（101）; 建立与频道信息相对应的频道列表项; 接收基于组管理协议的报告消息，用于加入组播组并从自定义边缘（CE）发送，其中报告消息包含信道信息（103）; 将所述频道列表项与所述CE相关联并且形成多播转发列表项（104）; 根据组播转发列表项，将从NPE接收的组播数据流发送到CE（105）。本发明可以节省UPE建立通道列表项的时间，从而缩短CE获取组播数据流的时间延迟。

5. 发明申请

WO2007128244A8 METHOD, OLIGONUCLEOTIDE PROBE AND TEST KIT OF PREDICTING RISK OF NEGATIVE PREGNANCY OUTCOMES, AND USE THEREOF 审中-公开
标题翻译：方法，预测负面责任风险的寡核苷酸探针和检测试剂盒及其用途
公开(公告)号：WO2007128244A8
公开(公告)日：2008-07-10
申请号：PCT/CN2007001491
申请日：2007-04-30
申请人： SHENZHEN AUSA PHARMED CO LTD , ANHUI MEDICAL UNIVERSITY BIOME , XU XIPING , XING HOUXUN , WANG BINYAN , LI ZHIPING , WU DI , ZANG TONGHUA
发明人： XU XIPING , XING HOUXUN , WANG BINYAN , LI ZHIPING , WU DI , ZANG TONGHUA
IPC分类号： G01N33/68 , C12N9/00 , C12Q1/68
CPC分类号： C12Q1/6883 , C12N9/48 , C12Q2600/156
摘要： Method, oligonucleotide probe and test kit of predicting risk of negative pregnancy outcomes, and use thereof by detecting polymorphism site E112D genotypes of prolylcarboxypeptidase (PRCP) gene in individuals. When the genotype is 112EE homozygous wild type, the risk of negative pregnancy outcomes is lower. When the genotype is 112ED heterozygous type or 112DD homozygous mutant type, the risk of negative pregnancy outcomes is higher.
摘要翻译：方法，寡核苷酸探针和预测阴性妊娠结局风险的检测试剂盒，并通过检测个体中脯氨酰羧肽酶（PRCP）基因多态性位点E112D基因型的应用。当基因型为112EE纯合野生型时，阴性妊娠结局的风险较低。当基因型为112ED杂合型或112DD纯合突变型时，阴性妊娠结局的风险较高。

6. 发明申请

WO2004055855A2 UNIFORM ETCH SYSTEM 审中-公开
标题翻译：均匀蚀刻系统
公开(公告)号：WO2004055855A2
公开(公告)日：2004-07-01
申请号：PCT/US2003/038617
申请日：2003-12-04
申请人： LAM RESEARCH CORPORATION , LARSON, Dean, J. , KADKHODAYAN, Babak , WU, Di , TAKESHITA, Kenji , YEN, Bi-Ming , SU, Xingcai , DENTY, William, M., Jr. , LOEWENHARDT, Peter
发明人： LARSON, Dean, J. , KADKHODAYAN, Babak , WU, Di , TAKESHITA, Kenji , YEN, Bi-Ming , SU, Xingcai , DENTY, William, M., Jr. , LOEWENHARDT, Peter
IPC分类号： H01J37/00
CPC分类号： G05D7/0664 , H01J37/3244 , H01L21/31116
摘要： An apparatus for providing different gases to different zones of a processing chamber is provided. A gas supply for providing an etching gas flow is provided. A flow splitter in fluid connection with the gas supply for splitting the etching gas flow from the gas supply into a plurality of legs is provided. A tuning gas system in fluid connection to at least one of the legs of the plurality of legs is provided.
摘要翻译：提供了一种用于向处理室的不同区域提供不同气体的装置。提供了用于提供蚀刻气体流的气体供应。提供了一种与气体供应流体连接的分流器，用于将来自气体供给的蚀刻气体流分解成多个支腿。提供了与多个腿部中的至少一个腿流体连接的调节气体系统。

7. 发明申请

WO2021056412A1 TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALS 审中-公开
公开(公告)号：WO2021056412A1
公开(公告)日：2021-04-01
申请号：PCT/CN2019/108510
申请日：2019-09-27
申请人： L'OREAL , WU, Di
发明人： YANG, Zhongxia
IPC分类号： A61K8/02 , A61K8/368 , A61K8/34 , A61Q19/00 , A61Q19/02
摘要： In a process for caring for keratin materials, the two parts of two-part composition are mixed to form a solution and then applied to the keratin materials. The two-part composition for caring for keratin materials comprises: a) an anhydrous part containing ferulic acid, and b) a hydrous part containing: i) at least one polyglycol with polymerization degree no more than 8, and ii) at least one C3-C6 glycol, wherein the anhydrous part and the hydrous part are separate.

8. 发明申请

WO2012071793A1 BIOLOGICAL WASTEWATER TREATMENT AND REUSE UTILIZING SULFUR COMPOUNDS AS ELECTRON CARRIER TO MINIMIZE SLUDGE PRODUCTION 审中-公开
标题翻译：生物废水处理和再利用硫化合物作为电子载体，以最大限度地减少泥沙生产
公开(公告)号：WO2012071793A1
公开(公告)日：2012-06-07
申请号：PCT/CN2011/002019
申请日：2011-12-02
申请人： THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY , CHEN, Guanghao , CHUI, Ho Kwong , LU, Hui , WU, Di , HAO, Tianwei , JIANG, Feng , VAN LOOSDRECHT, Marinus, Cornelis Maria
发明人： CHEN, Guanghao , CHUI, Ho Kwong , LU, Hui , WU, Di , HAO, Tianwei , JIANG, Feng , VAN LOOSDRECHT, Marinus, Cornelis Maria
IPC分类号： C02F3/30 , C02F3/12 , C02F3/28
CPC分类号： C02F3/025 , C02F3/2846 , C02F3/302 , C02F2101/101 , C02F2101/16 , C02F2101/163
摘要： Provided is a method of biological wastewater treatment of influent containing organic carbon, which is performed by oxidizing organic carbon with sulfur or a sulfur compound as an electron carrier, and reducing the sulfur or sulfur compound to sulfide. The sulfide is oxidized with nitrate or oxygen. If necessary, ammonia is oxidized to nitrate and then reduced to nitrogen gas. Also provided is a biological wastewater treatment plant. The method is effective for saline wastewater facilities, as well as non-saline wastewater facilities.
摘要翻译：提供了通过用硫或硫化合物作为电子载体氧化有机碳并将硫或硫化合物还原为硫化物来进行含有机碳的流入物的生物废水处理方法。硫化物用硝酸盐或氧气氧化。如果需要，氨被氧化成硝酸盐，然后还原成氮气。还提供了一个生物废水处理厂。该方法对盐水废水处理设施以及非盐水废水处理设施有效。

9. 发明申请

WO2010127399A1 GENE EXPRESSION PROFILES AND USES THEREOF 审中-公开
标题翻译：基因表达谱及其用途
公开(公告)号：WO2010127399A1
公开(公告)日：2010-11-11
申请号：PCT/AU2010/000524
申请日：2010-05-06
申请人： WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH , LINDEMAN, Geoffrey , SMYTH, Gordon , VISVADER, Jane , WU, Di
发明人： LINDEMAN, Geoffrey , SMYTH, Gordon , VISVADER, Jane , WU, Di
IPC分类号： C12Q1/68 , G01N33/48 , G01N35/00
CPC分类号： C12Q1/6886 , A61K31/00 , C12Q1/6881 , C12Q2600/112 , C12Q2600/158
摘要： A method for stratifying cancer in a subject comprising determining gene-set expression in a sample from a subject. The set is preselected from genes which are: (a) selectively or differentially expressed in CD49f + EpCAM + luminal epithelial progenitor cells compared to basal epithelial (MaSC enriched) or mature luminal epithelial cells; and/or (b) selectively or differentially expressed in CD49f hi EpCAM - basal epithelial progenitor cells compared to luminal progenitor and mature luminal epithelial cells; and/or (c) selectively or differentially expressed in CD49f - EpCAM + mature luminal epithelial cells compared to basal epithelial and luminal progenitor epithelial cells; and/or (d) selectively or differentially expressed in CD49f - EpCAM - stromal fibroblasts cells compared to basal epithelial and luminal epithelial cells. A method for diagnosis, prognosis or treatment of basal-like breast cancer and/or a BRCA1-deficiency associated form of cancer comprising (i) determining expression of a set of genes in a sample where the gene set is preselected to comprise genes which are selectively or differentially expressed in CD49f + EpCAM + epithelial luminal progenitor cells compared to their expression by control cells such as at least basal epithelial cells or mature luminal epithelial cells. Gene sets are provided in Tables 10 to 17. Preferred gene sets include KIT. Methods of treatment or prevention include administering agents that modulate the activity of gene set expression products, such as KIT polypeptide. Diagnostic probes and kits are included. Methods of reducing proliferation of normal or pre-neoplastic or neoplastic luminal progenitor cells in human mammary epithelium are provided including administering an agent that down modulates KIT activity.
摘要翻译：一种在受试者中分层癌症的方法，包括确定来自受试者的样品中的基因集表达。该基因是从以下基因中预先选择的：（a）与基底上皮（富含MaSC）或成熟腔上皮细胞相比，在CD49f + EpCAM +腔上皮祖细胞中选择性或差异表达; 和/或（b）与腔内祖细胞和成熟腔上皮细胞相比，在CD49fhiEpCAM-基础上皮祖细胞中选择性或差异表达; 和/或（c）与基底上皮和腔内祖细胞上皮细胞相比，在CD49f-EpCAM +成熟腔上皮细胞中选择性或差异表达; 和/或（d）与基底上皮和腔上皮细胞相比，在CD49f-EpCAM-间质成纤维细胞中选择性或差异表达。用于诊断，预后或治疗基底样乳腺癌和/或BRCA1缺陷相关形式的癌症的方法，其包括（i）确定样品中一组基因的表达，其中所述基因组被预先选择为包含与其对照细胞如至少基底上皮细胞或成熟腔上皮细胞的表达相比，在CD49f + EpCAM +上皮腔内祖细胞中选择性或差异表达。基因组在表10至17中提供。优选的基因组包括KIT。治疗或预防的方法包括调节基因集表达产物如KIT多肽的活性的给药剂。包括诊断探针和试剂盒。提供减少人乳腺上皮中正常或前肿瘤或肿瘤性腔内祖细胞增殖的方法，包括施用下调KIT活性的试剂。

10. 发明申请

WO2010126811A1 CXCR3 RECEPTOR ANTAGONISTS 审中-公开
标题翻译： CXCR3受体拮抗剂
公开(公告)号：WO2010126811A1
公开(公告)日：2010-11-04
申请号：PCT/US2010/032347
申请日：2010-04-26
申请人： BOEHRINGER INGELHEIM INTERNATIONAL GMBH , KOWALSKI, Jennifer A. , MARSHALL, Daniel Richard , PROKOPOWICZ, Anthony S. III , SCHLYER, Sabine , SIBLEY, Robert , SORCEK, Ronald John , WU, Di , WU, Frank , YOUNG, Erick Richard Roush
发明人： KOWALSKI, Jennifer A. , MARSHALL, Daniel Richard , PROKOPOWICZ, Anthony S. III , SCHLYER, Sabine , SIBLEY, Robert , SORCEK, Ronald John , WU, Di , WU, Frank , YOUNG, Erick Richard Roush
IPC分类号： C07D209/48 , C07D213/26 , C07D213/56 , C07D213/65 , C07D213/74 , C07D217/00 , C07D231/10 , C07D233/90 , C07D235/04 , C07D239/34 , C07D239/42 , C07D277/30 , C07D307/68 , C07D317/68 , C07D319/18
CPC分类号： C07D471/04 , C07D209/48 , C07D213/26 , C07D213/56 , C07D213/65 , C07D213/74 , C07D217/00 , C07D231/10 , C07D233/90 , C07D235/04 , C07D239/34 , C07D239/42 , C07D277/30 , C07D295/185 , C07D307/68 , C07D317/68 , C07D319/18 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D413/12 , C07D417/12 , C07D491/08
摘要： The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R 1 to R 5 , A, B, D and X are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
摘要翻译：本发明涉及式（I）化合物及其药学上可接受的盐，其中R1至R5，A，B，D和X如本文所定义。本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式